Trastuzumab Recruiting Phase 1 Trials for Cancer, Breast / Tumors, Solid Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03135171Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab
NCT02152943Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
NCT01969643A Safety Study of SGN-LIV1A in Breast Cancer Patients
NCT02562378T-DM1 and Non-pegylated Liposomal Doxorubicin in HER2-positive Metastatic Breast Cancer